Definium Therapeutics Inc. Common Shares vs Valley National Bancorp Common Stock — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while Valley National Bancorp Common Stock trades at $12.64 (market cap $6.90B). The key difference: Valley National Bancorp Common Stock is the larger of the two by market cap, and Valley National Bancorp Common Stock pays a 3.53% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Valley National Bancorp Common Stock for 0 Days on average.
| DFTX | VLY | |
|---|---|---|
Market Cap | $4.71B | $6.90B |
Volume | 1,966,636 | 8,032,586 |
Sector | Health | Financials |
52-Week High | $48.45 | $15.19 |
52-Week Low | $10.68 | $9.72 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.67B | $9.40B |
Dividend Yield | — | 3.53% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →Valley National Bancorp is a financial holding company whose main subsidiary is Valley National Bank. It provides commercial, retail, trust, and investment services across several U.S. states.
Read more on VLY →